HIV-1 Tat Protein Modulates the Generation of Cytotoxic T Cell Epitopes by Modifying Proteasome Composition and Enzymatic Activity1
暂无分享,去创建一个
Paola Rimessi | Arianna Bottoni | Antonella Caputo | A. Bottoni | A. Canella | R. Gavioli | A. Caputo | B. Ensoli | P. Rimessi | F. Micheletti | M. Fabris | A. Cafaro | C. Fortini | Barbara Ensoli | M. Marastoni | Eleonora Gallerani | Aurelio Cafaro | Riccardo Gavioli | Marina Fabris | Cinzia Fortini | Alessandro Canella | Angela Bonaccorsi | Mauro Marastoni | Fabiola Micheletti | A. Bonaccorsi | E. Gallerani
[1] S. H. van der Burg,et al. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumors , 1995, European journal of immunology.
[2] Luigi Buonaguro,et al. HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region , 1997, AIDS.
[3] M. Masucci,et al. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4 , 1993, Journal of virology.
[4] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[5] R. Preissner,et al. The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing. , 2002, Journal of molecular biology.
[6] A. Goldberg,et al. Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.
[7] A. Goldberg,et al. Proteasome Subunits X and Y Alter Peptidase Activities in Opposite Ways to the Interferon-γ-induced Subunits LMP2 and LMP7* , 1996, The Journal of Biological Chemistry.
[8] A. Goldberg,et al. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Wingfield,et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.
[10] J. Monaco,et al. β2 Subunit Propeptides Influence Cooperative Proteasome Assembly* , 2003, The Journal of Biological Chemistry.
[11] M. Kasahara,et al. The MHC class I ligand‐generating system: roles of immunoproteasomes and the interferon‐4gMY‐inducible proteasome activator PA28 , 1998, Immunological reviews.
[12] L. Kaer,et al. Immunoproteasome Assembly : Cooperative Incorporation of Interferon g ( IFN-g ) – inducible Subunits , 1997 .
[13] S. Volinia,et al. Supra-Agonist Peptides Enhance the Reactivation of Memory CTL Responses1 , 2000, The Journal of Immunology.
[14] A. Borsetti,et al. Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). , 2001, Vaccine.
[15] F. Khanim,et al. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 , 1993, Journal of virology.
[16] J. Sodroski,et al. Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. , 1990, Journal of acquired immune deficiency syndromes.
[17] A. Canella,et al. Selective amino acid substitutions of a subdominant Epstein‐Barr virus LMP2‐derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein‐Barr virus‐associated malignancies , 1999, European journal of immunology.
[18] J. Whitton,et al. Two Overlapping Subdominant Epitopes Identified by DNA Immunization Induce Protective CD8+ T-Cell Populations with Differing Cytolytic Activities , 2001, Journal of Virology.
[19] J. Monaco,et al. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits , 1997 .
[20] M. Masucci,et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. , 1993, Science.
[21] G R Stark,et al. Adenovirus E1A Down-regulates LMP2 Transcription by Interfering with the Binding of Stat1 to IRF1* , 2000, The Journal of Biological Chemistry.
[22] S. Salahuddin,et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.
[23] Jonathan W. Yewdell,et al. Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens , 2001, The Journal of experimental medicine.
[24] D. Moss,et al. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. , 1997, Annual review of immunology.
[25] Robert Huber,et al. Contribution of Proteasomal β-Subunits to the Cleavage of Peptide Substrates Analyzed with Yeast Mutants* , 1998, The Journal of Biological Chemistry.
[26] P. Kloetzel,et al. Human immunodeficiency virus‐1 Tat protein interacts with distinct proteasomal α and β subunits , 2003 .
[27] M. Probst-Kepper,et al. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. , 2000, Immunity.
[28] S. Burrows,et al. Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune recognition of EBV‐infected cells by LMP1‐specific cytotoxic T lymphocytes , 1998, European journal of immunology.
[29] A. Polack,et al. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines. , 1998, Journal of immunology.
[30] R. Tampé,et al. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. , 1997, Blood.
[31] A. Goldberg,et al. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. , 1993, Nature.
[32] S. Moretti,et al. Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses1 , 2002, The Journal of Immunology.
[33] J. Heeney,et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine , 1999, Nature Medicine.
[34] M. Masucci,et al. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells , 2001, Nature Cell Biology.
[35] Yuntao Wu,et al. Gene transcription in HIV infection. , 2003, Microbes and infection.
[36] E. Coccia,et al. Modulation of Human Immunodeficiency Virus 1 Replication by Interferon Regulatory Factors , 2002, The Journal of experimental medicine.
[37] K. Ferrell,et al. HIV-1 Tat Inhibits the 20 S Proteasome and Its 11 S Regulator-mediated Activation* , 1997, The Journal of Biological Chemistry.
[38] L. Kaer,et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. , 1998 .
[39] P. Kloetzel,et al. Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.
[40] H. Land,et al. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.
[41] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.